Background We previously showed microRNAs (miRNAs) in plasma are potential
biomarkers for colorectal cancer detection. Here, we aimed to develop specific blood-based …

Simple Summary Breast cancer diagnosis at the initial stage of the disease considerably
improves prognosis and survival rates. This retrospective study aimed to develop and …

Background Female breast cancer is frequently diagnosed at a later stage and the leading
cause of cancer deaths world-wide. Levels of cell-free circulating microRNAs (miRNAs) can …

Background Since recent studies revealed the feasibility to detect blood-based microRNAs
(miRNAs, miRs) in breast cancer (BC) patients a new field has been opened for circulating …

The expression of microRNAs (miRNAs) in a tissue-and development-specific manner has
indicated that they play an essential role in the maintenance of biological homeostasis. In …

Dysregulation of microRNAs (miRNAs) is involved in the initiation and progression of
several human cancers, including breast cancer (BC), as strong evidence has been found …

With a high mortality rate that accounts for millions of cancer-related deaths each year,
breast cancer is the second most common malignancy in women. Chemotherapy has …

Background Breast cancer is the leading cause of cancer related death in women, with
metastasis the principle cause of mortality. New non-invasive prognostic markers are …

Breast cancer (BC) is the most predominant type of cancer among women. The aim of this
study is to find new biomarkers that can help in early detection of BC, especially for those …

Abstract Purpose Circulating microRNAs (miRNAs) are potential diagnostic biomarkers for
breast cancer (BC). The application of miRNA panels could improve the performance of …